Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Interest & Investment Income (2023 - 2026)

Apyx Medical filings provide 3 years of Interest & Investment Income readings, the most recent being $234000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 20.41% to $234000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 31.01% decrease, with the full-year FY2025 number at $1.1 million, down 31.01% from a year prior.
  • Interest & Investment Income hit $234000.0 in Q4 2025 for Apyx Medical, down from $292000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $495000.0 in Q1 2024 to a low of $234000.0 in Q4 2025.
  • Median Interest & Investment Income over the past 3 years was $299000.0 (2024), compared with a mean of $340500.0.
  • Biggest five-year swings in Interest & Investment Income: soared 52.42% in 2024 and later plummeted 38.59% in 2025.
  • Apyx Medical's Interest & Investment Income stood at $443000.0 in 2023, then plummeted by 33.63% to $294000.0 in 2024, then dropped by 20.41% to $234000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $234000.0 (Q4 2025), $292000.0 (Q3 2025), and $278000.0 (Q2 2025) per Business Quant data.